Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Cell-mediated immune responses to influenza vaccination in Wegeners granulomatosis
Annals of Rheumatic Diseases, 07/23/09
Holvast A et al. – Study reports that cell-mediated responses to influenza vaccination in Wegener’s granulomatosis (WG) patients are comparable to those in healthy controls.
Methods- Aim was to determine the antibody and cell-mediated immune responses in the defense against influenza in WG pts
- 25 WG pts and healthy controls received subunit influenza vaccine
- PBMCs were obtained before and 1 month after vaccination
- Cell-mediated responses to A/H1N1 and A/H3N2 were assessed using IFN-γ ELISpot and intracellular cytokine staining for IFN-γ, TNF and IL-2
- Prior to vaccination, patients and controls showed similar recall responses to A/H1N1 and A/H3N2
- Following vaccination, pts and controls showed similar levels of increase in spot-forming cells against A/H1N1 and A/H3N2
- By flow cytometry, upon vaccination, proportions of cytokine-producing CD4+ T-cells increased in pts and controls for A/H1N1 and A/H3N2
Related Articles
Update on 2009 pandemic influenza A (H1N1) virus
Cleveland Clinic Journal of Medicine, 10/05/09
Relevance Score: 71%
Pandemic 2009 Influenza Update: Pandemrix data on co-administration with annual seasonal influenza vaccine
GlaxoSmithKline, 11/10/09
Relevance Score: 70%
H1N1 Vaccine Deliveries Begin. Early Doses to Arrive This Week
American Family Physician, 10/07/09
Relevance Score: 70%
Novartis completes shipment of US supply of Fluvirin seasonal influenza vaccine
Novartis, 10/07/09
Relevance Score: 70%
One Dose of H1N1 Vaccine Immunogenic in High Percentage of Youth Ages 10 to 17. Younger Children Likely Will Need Two Doses
American Family Physician, 10/05/09
Relevance Score: 70%
Today in Vasculitic Syndromes...keeping you current
Receive free subspecialty "5-minute updates" via email
Rituximab may form a complex with iGm[kappa] mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis
Arthritis & Rheumatism, 12/02/09
Imaging techniques in the evaluation of primary large vessel vasculitides
Zeitschrift für Rheumatologie, 12/01/09
Serum concentrations of interleukin 1î², cxcl10, and interferon-î³ in mixed cryoglobulinemia associated with hepatitis c infection
Journal of Rheumatology, 11/19/09
Sponsor
Article Search
Sponsor


See Latest Articles


